Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary Hypercholesterolemia
- 6 March 2001
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 103 (9), 1191-1193
- https://doi.org/10.1161/01.cir.103.9.1191
Abstract
Background—Long-term therapy with hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) has been shown to reduce levels of C-reactive protein (CRP). However, the generalizability, speed o...This publication has 9 references indexed in Scilit:
- Low grade inflammation and coronary heart disease: prospective study and updated meta-analysesBMJ, 2000
- Pleiotropic effects of statinsCurrent Atherosclerosis Reports, 2000
- Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Hypercholesterolaemia: The Pivotal Placebo-Controlled Clinical TrialJournal of International Medical Research, 2000
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenThe New England Journal of Medicine, 2000
- Clinical Efficacy of an Automated High-Sensitivity C-Reactive Protein AssayClinical Chemistry, 1999
- Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbitsBritish Journal of Pharmacology, 1999
- Effect of statins on C-reactive protein in patients with coronary artery diseaseThe Lancet, 1999
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenThe New England Journal of Medicine, 1997